Skip to main content
Home
FULL MENU Close Menu
Home
Home

Mark S. Lesney, PhD

News

Circulating miRNA could be a potential biomarker for early diagnosis of MM

Author:
Mark S. Lesney, PhD
Publish date: November 24, 2020

A meta-analysis found that using circulating microRNAs had high sensitivity and specificity in the early diagnosis of multiple myeloma.

  • Read More

News

Pigment traits, sun sensitivity associated with risk of non-Hodgkin lymphomas and chronic lymphocytic leukemia

Author:
Mark S. Lesney, PhD
Publish date: November 24, 2020

The presence of “many or very many nevi [moles]” was particularly associated with the risk of CLL.

  • Read More

News

Combo DAA treatments may benefit patients with resistant HCV genotype 3

Author:
Mark S. Lesney, PhD
Publish date: November 23, 2020

A variety of combo drug treatments proved effective in treating HCV genotype 3 to achieve sustained virologic response.

  • Read More

News

Hemophilia, von Willebrand disease do not increase postop complications for ACL reconstruction

Author:
Mark S. Lesney, PhD
Publish date: November 20, 2020

A case-control study showed outcomes were similar but hospital costs were significantly higher for patients with bleeding disorders.

  • Read More

Article

Opt-out policy at a syringe service program increased HIV/HCV testing

Author:
Mark S. Lesney, PhD
Publish date: November 16, 2020

For HIV and HCV among people who inject drugs, it is important to improve diagnosis and linkage to care.

  • Read More

News

Ibrutinib associated with decreased circulating malignant cells and restored T-cell function in CLL patients

Author:
Mark S. Lesney, PhD
Publish date: November 10, 2020

Ibrutinib showed decreased circulating malignant immune cells and restored healthy T-cell function in chronic...

  • Read More

News

Whales, seals, and dolphins: Will SARS-CoV-2–contaminated wastewater prove a killer?

Author:
Mark S. Lesney, PhD
Publish date: November 10, 2020

Environmental pollution during the COVID-19 pandemic puts dolphins, whales, seals, and otters among the sea...

  • Read More

News

Mouth splints decrease risk of post–dental extraction bleeding in hemophilia

Author:
Mark S. Lesney, PhD
Publish date: November 3, 2020

On average, post–dental extraction bleeding occurred 6 days after intervention and on the 5th postoperative day...

  • Read More

News

Socioeconomic factors affect survival of multiple myeloma patients

Author:
Mark S. Lesney, PhD
Publish date: October 22, 2020

Socioeconomic factors such as insurance and income play a significant role in creating survival disparities...

  • Read More

News

ESMO offers new clinical practice guideline for CLL

Author:
Mark S. Lesney, PhD
Publish date: October 21, 2020

New chronic lymphocytic leukemia guideline addresses diagnosis, treatment, and follow-up.

  • Read More

Article

Diffuse large B-cell lymphoma (DLBCL) of the small intestine with mucosal ulceration and invasion of the mesenteric fat tissue. H&E Stain.

Older age, r/r disease in lymphoma patients tied to increased COVID-19 death rate

Author:
Mark S. Lesney, PhD
Publish date: October 20, 2020

Patients younger than 70 years, without relapsed/refractory lymphoma had an 88% 30-day overall survival,...

  • Read More

News

Blood group O linked to decreased risk of SARS-CoV-2 infection

Author:
Mark S. Lesney, PhD
Publish date: October 15, 2020

A retrospective analysis of all Danish individuals with a known ABO blood group tested for SARS-CoV-2 showed a lower infection risk for SARS-CoV-2...

  • Read More

News

Study: Complications from childhood ALL and its treatment are common, but can be managed

Author:
Mark S. Lesney, PhD
Publish date: October 15, 2020

Despite survival after treatment of acute lymphoblastic leukemia, a high percentage of children suffered acute...

  • Read More

News

Older adults with multiple myeloma face heavy burden of care

Author:
Mark S. Lesney, PhD
Publish date: October 8, 2020

Newly diagnosed older adults with multiple myeloma (MM) face a heavy burden of treatment.

  • Read More

Article

Meta-analysis: Acalabrutinib showed better PFS and OS than other frontline CLL therapies

Author:
Mark S. Lesney, PhD
Publish date: October 7, 2020

Progression-free and overall survival improved with acalabrutinib over other chronic lymphocytic leukemia...

  • Read More

Pages

  • « first
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • last »

Privacy Policy

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2022 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close